Catalyst Wire Dossier Catalyst Wire Dossier

COPAXONE

GLATIRAMER ACETATE · Teva Neuroscience, Inc.
Drug timelines are a Plus or Pro feature.

60 regulatory and trial events tracked for COPAXONE, covering 2006-07-07 to 2025-01-22. Get the full timeline:

Most recent: FDA Approved: COPAXONE — Supplemental Application (Teva Neuroscience, Inc.)

See pricing